Open AccessPCSK9 Inhibitors in Lipid Management of Patients With Diabetes Mellitus and High Cardiovascular Risk: A Review
Author(s) -
Handelsman Yehuda,
Lepor Norman E.
Publication year - 2018
Publication title -
journal of the american heart association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.494
H-Index - 85
ISSN - 2047-9980
DOI - 10.1161/jaha.118.008953
Subject(s) - medicine , diabetes mellitus , dyslipidemia , myocardial infarction , cardiology , unstable angina , coronary artery disease , mace , statin , disease , endocrinology , percutaneous coronary intervention
Elevated levels of low‐density lipoprotein cholesterol (LDL‐C) are well established to be associated with the development of atherosclerotic cardiovascular disease (ASCVD), defined as acute coronary syndrome, a history of myocardial infarction, stable or unstable angina, coronary or other